VC2 vaccine - Rational Vaccines
Alternative Names: VC2; VC2 vaccineLatest Information Update: 25 Aug 2021
At a glance
- Originator Louisiana State University
- Class Attenuated vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Herpes simplex virus type 1 infections
Most Recent Events
- 05 Apr 2021 Rational Vaccines in-licenses VC2 vaccine technology from Louisiana State University
- 05 Apr 2021 Preclinical trials in Herpes simplex virus type 1 infections (Prevention) in USA (IM) before April 2021
- 05 Apr 2021 Pharmacodynamics data from a preclinical study in Herpes simplex virus type 1 infections released by Rational Vaccines